Connecting to SEC EDGAR… PricingSign in
← All filings

ANRO

Alto Neuroscience, Inc. SEC filings
Pharmaceutical Preparations · NYSE · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for ANRO right now.
Filing history
2026-10-30
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-10-05
Insider trade 4
Filing ↗
2026-10-01
Insider trade 4
Filing ↗
2026-09-29
Planned insider sale 144
Filing ↗
2026-08-27
Current report 8-K
Exec/director change
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-14
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-08-12
Quarterly report 10-Q
Filing ↗
2026-08-12
Current report 8-K
Earnings results
Filing ↗
2026-07-27
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-07-20
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-07-14
Current report 8-K
Material agreement
Filing ↗
2026-07-14
Prospectus 424B5
Filing ↗
2026-07-13
Current report 8-K
Earnings resultsOther event
Filing ↗
2026-05-29
Insider trade 4
Filing ↗
2026-05-29
New insider's holdings 3
Filing ↗
2026-05-28
Current report 8-K
Exec/director change
Filing ↗
2026-05-15
Insider trade 4
Filing ↗
2026-05-15
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-05-15
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-05-15
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-05-15
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-05-14
Insider trade 4
Filing ↗
2026-05-14
Insider trade 4
Filing ↗
2026-05-14
Insider trade 4
Filing ↗
2026-05-14
Insider trade 4
Filing ↗
2026-05-14
Insider trade 4
Filing ↗
2026-05-13
Current report 8-K
Exec/director changeShareholder vote
Filing ↗
2026-05-13
Quarterly report 10-Q
Filing ↗
2026-05-13
Current report 8-K
Earnings results
Filing ↗
2026-04-20
EFFECT EFFECT
Filing ↗
2026-04-17
CORRESP CORRESP
Filing ↗
2026-04-16
UPLOAD UPLOAD
Filing ↗
2026-04-10
Shelf registration (future share sales) S-3
Filing ↗
2026-04-01
Current report 8-K
Other event
Filing ↗
2026-03-26
Annual report to shareholders ARS
Filing ↗
2026-03-26
Proxy material DEFA14A
Filing ↗
2026-03-26
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-03-16
Current report 8-K
Material agreementShare sale (dilution)Other event
Filing ↗